Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGRA.L Regulatory News (GRA)

  • There is currently no data for GRA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Bond Issue

27 Sep 2022 12:56

RNS Number : 8701A
Grafenia plc
27 September 2022
 

Prior to publication, the information contained within this announcement was deemed by the Company to constitute inside information as stipulated under the UK Market Abuse Regulation. With the publication of this announcement, this information is now considered to be in the public domain.

 

27 September 2022

Grafenia plc

("Grafenia", the "Company" or the "Group")

 

Bond Issue

 

Grafenia plc (AIM: GRA) is pleased to announce that the Company has issued further bonds (the "Bonds") via the perpetual bond facility put in place in July 2020. The Company has issued £5.0 million of the Bonds, at nominal value, to investors, raising approximately £4.25 million before expenses. The key terms of the Bonds that have been issued are:

 

amount issued - £5.0 million;

 

issued at 85% of their nominal value;

 

no interest until July 2023;

 

thereafter, interest of 6% per annum payable annually in arrears;

 

trade date of 27 September 2022 and settlement date of 29 September 2022;

 

redeemable by the Company on 19 July 2023 or any anniversary thereafter;

 

admitted to trading in the Open Market on the Frankfurt Stock Exchange with ISIN DE000A28ZF69 and stock exchange abbreviation PF5A;

 

non-convertible;

 

unsecured - to rank pari passu with any past and future bonds.

 

The Bond was arranged by the Company's Settlement and Paying Agent Quirin Privatbank AG ("Quirin").

 

The net proceeds of the Bonds issued will be used to support the Company's acquisition strategy.

 

Related party transaction

 

Investmentaktiengesellschaft für langfristige Investoren TGV ("InvAG") is a Mutual Fund organised as an umbrella investment company with sub-funds and has subscribed for Bonds to the value of £800,000 at nominal value (a "Related Party Transaction"). InvAG is a related party of the Company for the purposes of the AIM Rules as it holds more than 10 per cent. of the ordinary shares of the Company, being 29.20 per cent.

 

 

 

JMX Capital GmbH, which is wholly owned by Jan-Hendrik Mohr the Company's Chairman, provides investment advice to Fiducia Treuhand AG, which in turn advises InvAG. As such, Mr Mohr is not considered independent for the purposes of the opinion required under the AIM Rules for the Related Party Transactions.

 

The Directors, excluding Jan Mohr, having consulted with the Company's Nominated Adviser, Allenby Capital, consider that the terms of the Related Party Transaction with InvAG are fair and reasonable insofar as the Shareholders are concerned.

 

Gavin Cockerill, Acting CEO of Grafenia commented "The funds being raised via the bond placing are for the acquisition of Vertical Plus Limited and other potential acquisitions we currently have in the pipeline, with a combined Turnover of c£4.0m, adjusted EBIT of c£1.3m and valuations typically between 4 and 5 times adjusted EBIT. It's an important first step in our acquisition strategy, now focussed on software businesses."

 

Market Abuse Regulation (MAR)

 

MAR came into effect from 3 July 2016. Market soundings, as defined in MAR, were taken in respect of the Bonds with the result that certain persons became aware of inside information, as permitted by MAR. That inside information was disclosed as soon as possible in accordance with paragraph 7 of article 17 of MAR and was set out in the Company's announcement on 22 September 2022. Therefore, those persons that received inside information in a market sounding are no longer in possession of inside information relating to the Company and its securities.

 

For further information:

 

Grafenia plc

Gavin Cockerill (Acting CEO) 07968 510 662

 

Allenby Capital Limited (Nominated Adviser and broker) 0203 328 5656

David Hart / Piers Shimwell

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IODBKOBPDBKDPCB
Date   Source Headline
22nd Feb 20181:49 pmRNSHolding(s) in Company
20th Feb 201810:42 amRNSTransaction in Own Shares
23rd Jan 20187:00 amRNSDirectorate Change
23rd Nov 20175:26 pmRNSHolding(s) in Company
23rd Nov 20175:14 pmRNSDirector/PDMR Shareholding
10th Nov 20179:28 amRNSDirector/PDMR Shareholding
8th Nov 201711:18 amRNSDirector/PDMR Shareholding
7th Nov 20173:19 pmRNSDirector/PDMR Shareholding
6th Nov 20177:00 amRNSHalf-year Report
27th Oct 20173:44 pmRNSHolding(s) in Company
27th Oct 201712:25 pmRNSHolding(s) in Company
28th Jul 201712:31 pmRNSResult of AGM
28th Jul 20177:00 amRNSAGM Statement
17th Jul 20177:00 amRNSAcquisition
7th Jun 20177:00 amRNSFinal Results
16th May 20178:12 amRNSTrading Update and board changes - Replacement
10th Apr 20177:00 amRNSTrading Update, board changes & notice of results
24th Feb 20177:00 amRNSDirector/PDMR Sharedealing
24th Feb 20177:00 amRNSEmployee Share Scheme
21st Feb 20177:00 amRNSTrading update
16th Jan 20177:00 amRNSAcquisition
8th Dec 201610:45 amRNSHolding(s) in Company
16th Nov 20163:08 pmRNSDirector/PDMR Shareholding
9th Nov 201612:24 pmRNSDirectors' Dealings
8th Nov 20167:00 amRNSHalf-year Report
14th Oct 20167:00 amRNSPeriod End Trading Update and Notice of Results
26th Aug 20168:16 amRNSTransaction in Own Shares
15th Aug 20163:55 pmRNSDirectorate Change
15th Aug 20167:00 amRNSTransaction in Own Shares
5th Aug 20167:00 amRNSAGM Statement
14th Jun 201611:28 amRNSHolding(s) in Company
9th Jun 201611:22 amRNSHolding(s) in Company
8th Jun 20167:12 amRNSFinal Results
3rd May 20168:12 amRNSHolding(s) in Company
19th Apr 20164:24 pmRNSHolding(s) in Company
7th Apr 20167:00 amRNSTrading Statement
24th Mar 201612:23 pmRNSHolding(s) in Company
15th Mar 20167:00 amRNSDirectorate Change
29th Feb 20167:00 amRNSTransaction in Own Shares
24th Feb 20167:00 amRNSTrading Update
12th Feb 20163:01 pmRNSDirector/PDMR Shareholding
12th Feb 20168:30 amRNSHolding(s) in Company
21st Jan 20162:05 pmRNSHolding(s) in Company
2nd Dec 20152:38 pmRNSHolding(s) in Company
27th Nov 20158:20 amRNSHolding(s) in Company
24th Nov 20153:34 pmRNSHolding(s) in Company
23rd Nov 201512:14 pmRNSHolding(s) in Company
19th Nov 20152:57 pmRNSHolding(s) in Company
18th Nov 20151:33 pmRNSDirector/PDMR Shareholding
16th Nov 20158:06 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.